Literature DB >> 11819276

Study of heteroserum-induced rat liver fibrosis model and its mechanism.

Zhi-Gang Huang, Wei-Rong Zhai, Yue-E Zhang, Xiu-Rong Zhang.   

Abstract

AIM:To investigate the morphological changes in the process of heteroserum induced rat liver fibrosis and the mechanism of fibrogenesis of this model.
METHODS: A model of heteroserum-induced rat liver fibrosis was established by intraperitoneal injection of porcine serum. In addition to the observation of the morphological changes of this model, the infiltration of eosinophils and mast cells were measured quantitatively and the deposition of IgG and complement C(3) was detected by immunofluorescence.
RESULTS: The rat liver fibrosis was induced successfully at the end of the 8th week after the injection of heteroserum.Besides the increase of hepatic stellate cells (HSC) during the process of liver fibrosis,proliferation and activation of primary mesenchyma cells (PMCs) were also found.In the early stage, the infiltration of eosinophils and mast cells was significantly increased and the deposition of IgG and complement C(3) was positive in the portal tracts and septa, while gradually reduced after the injection was stopped.
CONCLUSION: This model is suitable for the research on liver fibrogenesis; the pathogenesis of this model may be related with the allergen-induced late phase reaction (LPR) caused by the injection of heteroserum, and the HSCs and the PMCs are important sources of ECM-producing cells.

Entities:  

Year:  1998        PMID: 11819276      PMCID: PMC4723457          DOI: 10.3748/wjg.v4.i3.206

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  6 in total

1.  Chronic liver injury induced by immunologic reactions. Cirrhosis following immunization with heterologous sera.

Authors:  F Paronetto; H Popper
Journal:  Am J Pathol       Date:  1966-12       Impact factor: 4.307

2.  Cellular distribution of transforming growth factor-beta 1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis.

Authors:  H Nakatsukasa; P Nagy; R P Evarts; C C Hsia; E Marsden; S S Thorgeirsson
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

3.  Cellular localization of transforming growth factor-beta expression in bleomycin-induced pulmonary fibrosis.

Authors:  K Zhang; K C Flanders; S H Phan
Journal:  Am J Pathol       Date:  1995-08       Impact factor: 4.307

4.  Tissue eosinophilia and eosinophil degranulation in syndromes associated with fibrosis.

Authors:  H Noguchi; G M Kephart; T V Colby; G J Gleich
Journal:  Am J Pathol       Date:  1992-02       Impact factor: 4.307

5.  Transforming growth factor-beta protein and mRNA in glomeruli in normal and diseased human kidneys.

Authors:  K Yoshioka; T Takemura; K Murakami; M Okada; S Hino; H Miyamoto; S Maki
Journal:  Lab Invest       Date:  1993-02       Impact factor: 5.662

6.  Role of mesenchymal cell populations in porcine serum-induced rat liver fibrosis.

Authors:  E Bhunchet; K Wake
Journal:  Hepatology       Date:  1992-12       Impact factor: 17.425

  6 in total
  15 in total

1.  Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 expression in fibrotic rat liver.

Authors:  Hai-Lin Liu; Xuan-Hai Li; Dan-Yi Wang; Shao-Ping Yang
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

2.  CYP11B2 expression in HSCs and its effect on hepatic fibrogenesis.

Authors:  Xu Li; Ying Meng; Xi-Shan Yang; Ping-Sheng Wu; Shu-Mei Li; Wen-Yan Lai
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

3.  Expression changes of activin A in the development of hepatic fibrosis.

Authors:  X Huang; D G Li; Z R Wang; H S Wei; J L Cheng; Y T Zhan; X Zhou; Q F Xu; X Li; H M Lu
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

4.  Effects of AT1 receptor antagonist, losartan, on rat hepatic fibrosis induced by CCl(4).

Authors:  Hong-Shan Wei; Ding-Guo Li; Han-Ming Lu; Yu-Tao Zhan; Zhi-Rong Wang; Xin Huang; Jing Zhang; Ji-Lin Cheng; Qin-Fang Xu
Journal:  World J Gastroenterol       Date:  2000-08       Impact factor: 5.742

5.  Inhibiting effect of antisense oligonucleotides phosphorthioate on gene expression of TIMP-1 in rat liver fibrosis.

Authors:  Q H Nie; Y Q Cheng; Y M Xie; Y X Zhou; Y Z Cao
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

6.  The regulatory role of AT 1 receptor on activated HSCs in hepatic fibrogenesis:effects of RAS inhibitors on hepatic fibrosis induced by CCl(4).

Authors:  Hong-Shan Wei; Han-Ming Lu; Ding-Guo Li; Yu-Tao Zhan; Zhi-Rong Wang; Xin Huang; Ji-Lin Cheng; Qin-Fang Xu
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

7.  Methodologic research on TIMP-1, TIMP-2 detection as a new diagnostic index for hepatic fibrosis and its significance.

Authors:  Qing-He Nie; Yong-Qian Cheng; Yu-Mei Xie; Yong-Xing Zhou; Xian-Guang Bai; Yi-Zhan Cao
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

8.  Inhibition on the production of collagen type I, III of activated hepatic stellate cells by antisense TIMP-1 recombinant plasmid.

Authors:  Wen-Bin Liu; Chang-Qing Yang; Wei Jiang; Yi-Qing Wang; Jing-Sheng Guo; Bo-Ming He; Ji-Yao Wang
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

9.  Therapeutic effects and molecular mechanisms of anti-fibrosis herbs and selenium on rats with hepatic fibrosis.

Authors:  Yu-Tong He; Dian-Wu Liu; Li-Yu Ding; Qing Li; Yong-Hong Xiao
Journal:  World J Gastroenterol       Date:  2004-03-01       Impact factor: 5.742

10.  Effects of endothelin-1 on hepatic stellate cell proliferation, collagen synthesis and secretion, intracellular free calcium concentration.

Authors:  Chuan-Yong Guo; Jian-Ye Wu; Yun-Bin Wu; Min-Zhang Zhong; Han-Ming Lu
Journal:  World J Gastroenterol       Date:  2004-09-15       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.